DEFRANCESCO, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 281
EU - Europa 164
AS - Asia 86
Continente sconosciuto - Info sul continente non disponibili 1
Totale 532
Nazione #
US - Stati Uniti d'America 281
IE - Irlanda 95
CN - Cina 65
FI - Finlandia 19
IT - Italia 17
SG - Singapore 16
DE - Germania 15
SE - Svezia 11
BE - Belgio 3
IN - India 2
JP - Giappone 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CZ - Repubblica Ceca 1
FR - Francia 1
MY - Malesia 1
Totale 532
Città #
Dublin 95
Chandler 71
Boardman 34
Ashburn 21
Helsinki 19
Shanghai 14
Wilmington 13
Lawrence 12
Princeton 12
Medford 10
Singapore 9
Beijing 8
Ann Arbor 6
Falls Church 6
Los Angeles 6
Seattle 6
Nanjing 5
Shenyang 5
Nanchang 4
New York 4
Brussels 3
Washington 3
Casatenovo 2
Chicago 2
Falkenstein 2
Jacksonville 2
Jiaxing 2
Paratico 2
Pune 2
Redwood City 2
Tokyo 2
Wuhan 2
Xi'an 2
Altoona 1
Baoding 1
Berlin 1
Cangzhou 1
Chengdu 1
Clifton 1
Fairfield 1
Fuzhou 1
Guangzhou 1
Hamburg 1
Handan 1
Hangzhou 1
Hebei 1
Houston 1
Ningbo 1
Norwalk 1
Novokuznetsk 1
Nuremberg 1
Pavia 1
Prague 1
San Francisco 1
Santa Clara 1
Selangor 1
Shijiazhuang 1
St Petersburg 1
Xiangtan 1
Zhengzhou 1
Totale 415
Nome #
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. 50
Overview on the management of non-gastric MALT lymphomas 49
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders 49
Bing-Neel syndrome: Illustrative cases and comprehensive review of the literature 47
Mantle cell lymphoma of mucosa-associated lymphoid tissue: A european mantle cell lymphoma network study 43
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders 41
Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis 37
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi 37
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection 37
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network 36
HCV infection and non-Hodgkin lymphomas: an evolving story 35
Early progression as a predictor of survival in marginal zone lymphomas: An analysis from the FIL-NF10 study 33
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis 25
Pre-Treatment with Bendamustine Does Not Affect Stem Cell Mobilization in Patients with Indolent Non-Hodgkin Lymphomas: A Multicenter Study on Behalf of the Fondazione Italiana Linfomi 14
Endothelial biomarkers and risk of acute graft-versus-host disease after allogeneic stem cell transplantation: preliminary analysis of a single centre study 13
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study 7
Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infection 7
Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin's B lymphoma: a single center prospective clinico-pathological study 5
Totale 565
Categoria #
all - tutte 3.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 5 2
2020/202145 0 0 1 1 1 16 1 13 7 0 2 3
2021/202266 0 0 1 0 4 8 1 3 6 5 7 31
2022/2023213 18 25 2 6 16 16 0 9 107 0 11 3
2023/2024159 23 22 7 4 8 23 1 14 2 5 22 28
2024/202550 9 20 9 7 5 0 0 0 0 0 0 0
Totale 565